COG 133 TFA

Tax included
COG 133 TFA is a fragment of Apolipoprotein E (APOE) peptide. COG 133 TFA competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 TFA is also a nAChR antagonist with an IC50 of 445 nM.
MedChemExpress 
HY-P1050A

Data sheet

Size
Multiple sizes
Reactivity
nAChR
Application
COVID-19-immunoregulation